OpenVSafe by OpenVAERS
Search V-safe

258-70842-03423

4 vaccinations 11 coded responses 46 check-ins 11 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
432 / OH
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Registered in v-safe
  2. 2021-01-11
    Dose 1 — Moderna
  3. 2021-01-11
    Survey response — day 0, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness, Diarrhea
    Free text: Supraclavicular lymph node swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Concern about headache - currently being treated for pseudotumor cerebri/idiopathic intracranial hypertension (pre-existing condition)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-08
    Dose 2 — Moderna
  15. 2021-02-08
    Survey response — day 0, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Free text: Cervical, supraclavicular, and axillary lymph node swelling on injection side
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Lymphadenitis — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Axillary lymph node swelling, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  18. 2021-02-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Axillary lymph node swelling on side of injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Lymphadenopathy, Tenderness — Feeling: Fair · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Axillary lymph node swelling and tenderness, mild dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Muscle or body aches, Fatigue or tiredness
    Free text: Axillary lymph node swelling (injection side) - mild
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Fatigue or tiredness
    Free text: Axillary lymph node swelling on side of injection - mild
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-15
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · Fatigue or tiredness
    Free text: Axillary lymph node swelling (mild)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-05-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-10-27
    Dose 3 — Moderna
  31. 2021-10-27
    Health check-in — day 0, dose 3
    Feeling: Fair · None
    Adult check-in
  32. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  33. 2021-10-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Lymph node swelling (axillary)
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  35. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-11-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-11-03
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  39. 2021-11-10
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-17
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-24
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  42. 2021-12-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-12-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-01-26
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-04-27
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-10-08
    Dose 4 — Pfizer-BioNTech
  47. 2022-10-22
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-10-29
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  49. 2022-11-05
    Survey response — day 28, dose 4
    MedDRA: Sinusitis — Feeling: Fair
    Free text: Sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-11-12
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-11-19
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  52. 2023-04-08
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Moderna
22021-02-08Moderna
32021-10-27Moderna No
42022-10-08Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 0, dose 1

2021-01-11

Systemic reaction (other): Supraclavicular lymph node swelling

Release 1 — days 1–6 daily, dose 1

2021-01-12

Systemic reaction (other): Concern about headache - currently being treated for pseudotumor cerebri/idiopathic intracranial hypertension (pre-existing condition)

Release 3 — day 0, dose 2

2021-02-08

Systemic reaction (other): Cervical, supraclavicular, and axillary lymph node swelling on injection side

Release 3 — days 1–6 daily, dose 2

2021-02-09

Systemic reaction (other): Axillary lymph node swelling, dizziness

Release 4 — days 1–6 daily, dose 2

2021-02-11

Systemic reaction (other): Axillary lymph node swelling on side of injection

2021-02-12

Systemic reaction (other): Axillary lymph node swelling and tenderness, mild dizziness

2021-02-13

Systemic reaction (other): Axillary lymph node swelling (injection side) - mild

2021-02-14

Systemic reaction (other): Axillary lymph node swelling on side of injection - mild

Release 4 — day 7, dose 2

2021-02-15

Systemic reaction (other): Axillary lymph node swelling (mild)

Release 10 — days 1–6 daily, dose 3

2021-10-29

Systemic reaction (other): Lymph node swelling (axillary)

Release 12 — day 28, dose 4

2022-11-05

Symptoms: Sinus infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDSinusitis · · ✓
SROCondition aggravated ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHeadache ○ ○ ○
SROLymphadenitis ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release